CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

Showing 8 of 8 entries

View as:

Phase: N/A Priority: Normal

NCT ID: NCT01285700 Org: User:

Start: 01/31/11 End: 11/30/12 Due: 11/30/13

Phase: N/A Priority: Normal

NCT ID: NCT00418795 Org: User:

Start: 06/11/03 End: 06/20/06 Due: 06/20/07

Phase: N/A Priority: Normal

NCT ID: NCT01681953 Org: User:

Start: 08/31/12 End: 05/31/14 Due: 05/31/15

Phase: N/A Priority: Normal

NCT ID: NCT00498420 Org: User:

Start: 05/31/07 End: 11/30/09 Due: 11/30/10

Phase: N/A Priority: Normal

NCT ID: NCT01268358 Org: User:

Start: 10/31/10 End: 01/31/11 Due: 01/31/12

Phase: N/A Priority: Normal

NCT ID: NCT00983879 Org: User:

Start: 09/30/09 End: 07/31/14 Due: 07/31/15

Phase: N/A Priority: Normal

NCT ID: NCT01681940 Org: User:

Start: 01/31/12 End: 09/30/13 Due: 09/30/14

Phase: N/A Priority: Normal

NCT ID: NCT02478840 Org: User:

Start: 02/28/15 End: 06/30/15 Due: 06/30/16

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis	NCT01285700	Zymenex A/S	user2@example.com	None	2011-01-31	2012-11-30	2013-11-30	-	-	2025-07-14
Porphozym in the Treatment of Acute Attacks in AIP	NCT00418795	Zymenex A/S	user2@example.com	None	2003-06-11	2006-06-20	2007-06-20	-	-	2025-07-14
A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis	NCT01681953	Zymenex A/S	user2@example.com	None	2012-08-31	2014-05-31	2015-05-31	-	-	2025-07-14
The Natural History of Alpha-Mannosidosis	NCT00498420	Zymenex A/S	user2@example.com	None	2007-05-31	2009-11-30	2010-11-30	-	-	2025-07-14
Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis	NCT01268358	Zymenex A/S	user2@example.com	None	2010-10-31	2011-01-31	2012-01-31	-	-	2025-07-14
The Natural History of Infantile Globoid Cell Leukodystrophy	NCT00983879	Zymenex A/S	user2@example.com	None	2009-09-30	2014-07-31	2015-07-31	-	-	2025-07-14
Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis	NCT01681940	Zymenex A/S	user2@example.com	None	2012-01-31	2013-09-30	2014-09-30	-	-	2025-07-14
Evaluation of Long-term Efficacy of Treatment With Lamazym	NCT02478840	Zymenex A/S	user2@example.com	None	2015-02-28	2015-06-30	2016-06-30	-	-	2025-07-14